Targeting hydrogen sulfide breakdown for regulation of myocardial injury and repair
Item Status
Embargo End Date
Date
Authors
Emerson, Barry
Abstract
Hydrogen sulfide (H2S) is an endogenous gasotransmitter that regulates vascular function
and blood pressure, and also protects the heart from injury associated with myocardial
infarction (MI). The mitochondrial enzyme thiosulfate sulfurtransferase (TST) has a putative
role in the breakdown of H2S but its role in the cardiovascular system is unknown. I
hypothesised that TST reduces cardiovascular H2S availability and that inhibiting TST
activity may therefore ameliorate cardiovascular pathology.
In the heart, TST was expressed by cardiomyocytes and vascular smooth muscle cells. Tst-/-
mice all survived to adulthood and had normal cardiac structure and function. Cardiac and
hepatic H2S breakdown rates were reduced and H2S levels were higher in the blood of Tst-/-
mice. However, in heart tissue, protein levels for the H2S-activated Nrf2 downstream targets,
thioredoxin (Trx1) and heme oxygenase-1 (HO-1) were comparable. In contrast, protein
levels for the cardiac specific H2S-synthetic enzyme, cystathionine gamma lyase (CSE) was
reduced, suggesting a homeostatic negative feedback mechanism to maintain H2S at non-toxic
levels. Respiration, measured using an oxygen-sensing electrode was normal in
isolated mitochondria from whole Tst-/- compared to control C57BL6 hearts. Endothelial
nitric oxide synthase (eNOS) protein expression was lower in Tst-/- hearts, highlighting
potential cross talk between H2S and nitric oxide (NO) signalling.
TST was expressed in whole aorta homogenates and in isolated endothelial cells from aorta
and small intramuscular vessels of the hindlimb from C57BL/6N control mice. Myography
and western blotting revealed a greater influence of NO in aorta from Tst-/- mice that was
associated with increased phosphorylation of the activating serine1177 residue of eNOS (PeNOSSer1177).
NO plays a lesser role in resistance arteries, but in comparison to control
vessels, small mesenteric vessels from Tst-/- mice was more reliant on small and intermediate
calcium activated potassium channels for relaxation.
Tst-/- mice were normotensive, despite this alteration in the regulation of vascular tone.
However, metabolic cage experiments identified that Tst-/- mice presented with diuresis,
polydipsia, and increased urinary electrolyte excretion of sodium, potassium and chloride,
possibly to compensate for increased vascular tone in order to maintain stable blood
pressure.
To investigate the role of TST in regulating the response to pathological challenge, MI was
induced by coronary artery ligation (CAL). In control mice, gene expression of CSE was
downregulated by 2 days after CAL, but TST expression was 12-fold increased, suggesting
regulation of H2S bioavailability during the acute MI-healing phase. Tst-/- male mice had a
40% greater incidence of cardiac rupture during infarct healing and surviving Tst-/- mice had
greater left ventricular dilatation and impaired function compared to controls. Ex vivo,
isolated perfused hearts from Tst-/- mice were more susceptible to ischaemia/ reperfusion
injury, suggesting an additional role of TST in determining cardiomyocyte susceptibility to
injury.
In conclusion, these data indicate that cardiovascular H2S bioavailability is regulated through
degradation by TST. The data presented here provide evidence for significant tissue specific
crosstalk between H2S synthetic and degradative mechanisms and between H2S and other
local regulatory mechanisms, including ion channels and NOS. We infer TST has a
physiological role in the kidney where its loss leads to changes in renal electrolyte and water
handling, although other compensatory mechanisms prevent a change in blood pressure.
Under conditions of pathological challenge following MI, loss of TST is detrimental,
illustrating its key role in removal of H2S. The data refute the original hypothesis that TST
inhibition would be protective against cardiovascular pathology. Further studies in mice
with tissue specific deletion of TST are now required to more fully reveal the cardiovascular
role of TST.
This item appears in the following Collection(s)

